Global Pharmaceutical Products and CMO Market Growth (Status and Outlook) 2023-2029

Global Pharmaceutical Products and CMO Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Pharmaceutical Products and CMO Industry Forecast” looks at past sales and reviews total world Pharmaceutical Products and CMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Products and CMO sales for 2023 through 2029. With Pharmaceutical Products and CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Products and CMO industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Products and CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Products and CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Products and CMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Products and CMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Products and CMO.

The global Pharmaceutical Products and CMO market size is projected to grow from US$ 145080 million in 2022 to US$ 211010 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.

United States market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pharmaceutical Products and CMO players cover Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Products and CMO market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Active Pharmaceutical Ingredient (API)
Finished Dosage Form (FDF)
Pharmaceutical Packaging

Segmentation by application
Specialty/Midsize
Generics
Big Pharma
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma Technologies
Dishman
Aesica

Please note: The report will take approximately 2 business days to prepare and deliver. Show more